In a report released today, Kyle Bauser from Roth MKM reiterated a Buy rating on Electromed, with a price target of $35.00. The company’s shares closed last Friday at $24.10.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
According to TipRanks, Bauser is an analyst with an average return of -10.9% and a 38.91% success rate. Bauser covers the Healthcare sector, focusing on stocks such as Sanuwave Health, InfuSystem Holdings, and Electromed.
Currently, the analyst consensus on Electromed is a Strong Buy with an average price target of $30.33.
ELMD market cap is currently $201.2M and has a P/E ratio of 28.43.
Based on the recent corporate insider activity of 19 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of ELMD in relation to earlier this year.
Read More on ELMD:
/Semiconductor%20by%20Gorodenkoff%20via%20Shutterstock.jpg)
/An%20image%20of%20a%20Tesla%20humanoid%20robot%20in%20front%20of%20the%20company%20logo%20Around%20the%20World%20Photos%20via%20Shutterstock.jpg)
